SEC Filings

Filing date	Form	Description	View
02/28/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-026831.pdf 0001104659-23-026831.rtf 0001104659-23-026831.xls
04/11/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-044051.pdf 0001104659-23-044051.rtf
04/11/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-044052.pdf 0001104659-23-044052.rtf 0001104659-23-044052.xls
12/21/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-128307.pdf 0001104659-23-128307.rtf
09/27/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-009371.pdf 0001047469-13-009371.rtf 0001047469-13-009371.xls
10/29/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-010050.pdf 0001047469-13-010050.rtf 0001047469-13-010050.xls
11/22/13	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-13-010796.pdf 0001047469-13-010796.rtf 0001047469-13-010796.xls
04/08/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-003560.pdf 0001047469-14-003560.rtf 0001047469-14-003560.xls
04/30/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-004381.pdf 0001047469-14-004381.rtf 0001047469-14-004381.xls
05/07/14	10-12B/A	Amendment to a previously filed 10-12B	View HTML 0001047469-14-004658.pdf 0001047469-14-004658.rtf 0001047469-14-004658.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools